Stocks
Moderna gets a shot in the arm
Shares exploded over 140% higher.
Follow pharmaceutical company stocks—blockbuster drugs, patent cliffs, pipeline depth, and pricing policy risks affecting pharma valuations.
Shares exploded over 140% higher.
But Wall Street isn't convinced it will work.
Big Pharma is hunting for its next blockbuster.
Abbvie's acquisition of Apogee is a sign of the times.
Big pharma is eyeing the future.
Stay up to date on the latest market news with daily analysis of the investing landscape, served up Brew-style.
By subscribing, you accept our Terms & Privacy Policy.